BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33271565)

  • 1. Evaluation of Elafin Immunohistochemical Expression as Marker of Cervical Cancer Severity.
    Longatto-Filho A; Fregnani JH; Mafra da Costa A; de Araujo-Souza PS; Scapulatempo-Neto C; Herbster S; Boccardo E; Termini L
    Acta Cytol; 2021; 65(2):165-174. PubMed ID: 33271565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer.
    Liu H; Liu S; Wang H; Xie X; Chen X; Zhang X; Zhang Y
    Diagn Pathol; 2012 Oct; 7():147. PubMed ID: 23107094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
    Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence.
    Caruso JA; Karakas C; Zhang J; Yi M; Albarracin C; Sahin A; Bondy M; Liu J; Hunt KK; Keyomarsi K
    Breast Cancer Res; 2014; 16(6):3417. PubMed ID: 25551582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lgr5 is a potential prognostic marker in patients with cervical carcinoma.
    Sun B; Ye X; Li Y; Zhang W
    Int J Clin Exp Pathol; 2015; 8(2):1783-9. PubMed ID: 25973068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer.
    Hazelbag S; Kenter GG; Gorter A; Fleuren GJ
    Int J Cancer; 2004 Dec; 112(6):1020-8. PubMed ID: 15386352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of polymorphisms in the peptidase inhibitor 3 (elafin) gene and validation of their contribution to risk of acute respiratory distress syndrome.
    Tejera P; O'Mahony DS; Owen CA; Wei Y; Wang Z; Gupta K; Su L; Villar J; Wurfel M; Christiani DC
    Am J Respir Cell Mol Biol; 2014 Aug; 51(2):262-72. PubMed ID: 24617927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocytochemical detection of raf kinase inhibitor protein and human papillomavirus profiling of normal and abnormal cervical ThinPrep samples.
    Al-Awadhi R; Husain S; Chehadeh W; Al-Jassar W; Kapila K; Al-Mulla F
    Acta Cytol; 2013; 57(3):259-65. PubMed ID: 23636063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome.
    Liu Y; Alqatari M; Sultan K; Ye F; Gao D; Sigel K; Zhang D; Kalir T
    Hum Pathol; 2017 Aug; 66():144-151. PubMed ID: 28705710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A genome-wide expression analysis in blood identifies pre-elafin as a biomarker in ARDS.
    Wang Z; Beach D; Su L; Zhai R; Christiani DC
    Am J Respir Cell Mol Biol; 2008 Jun; 38(6):724-32. PubMed ID: 18203972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of elafin against adult asthma.
    Tsai YS; Tseng YT; Chen PS; Lin MC; Wu CC; Huang MS; Wang CC; Chen KS; Lin YC; Wang TN
    Allergy Asthma Proc; 2016; 37(2):15-24. PubMed ID: 26932165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
    Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
    Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elafin is related to immune infiltration and could predict the poor prognosis in ovarian cancer.
    Lu W; Xie B; Tan G; Dai W; Ren J; Pervaz S; Li K; Li F; Wang Y; Wang M
    Front Endocrinol (Lausanne); 2023; 14():1088944. PubMed ID: 36742380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus DNA, HPV L1 capsid protein and p16
    Hu H; Zhao J; Yu W; Zhao J; Wang Z; Jin L; Yu Y; Han L; Wang L; Zhu H; Li F
    Arch Gynecol Obstet; 2019 Jan; 299(1):141-149. PubMed ID: 30390110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of immunohistochemistry for p16 and GATA3 and molecular HPV typing in diagnosis of secondary bladder involvement by cervical carcinoma].
    Huang RF; He C; Zhu WF; Li Y; Chen G
    Zhonghua Bing Li Xue Za Zhi; 2017 Jun; 46(6):388-392. PubMed ID: 28591985
    [No Abstract]   [Full Text] [Related]  

  • 16.
    Cao CH; Liu R; Lin XR; Luo JQ; Cao LJ; Zhang QJ; Lin SR; Geng L; Sun ZY; Ye SK; Yu ZY; Shi Y; Xia X
    Int J Biol Sci; 2021; 17(7):1744-1756. PubMed ID: 33994859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival.
    Clauss A; Ng V; Liu J; Piao H; Russo M; Vena N; Sheng Q; Hirsch MS; Bonome T; Matulonis U; Ligon AH; Birrer MJ; Drapkin R
    Neoplasia; 2010 Feb; 12(2):161-72. PubMed ID: 20126474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancer.
    Branca M; Ciotti M; Giorgi C; Santini D; Di Bonito L; Costa S; Benedetto A; Bonifacio D; Di Bonito P; Paba P; Accardi L; Syrjänen S; Favalli C; Syrjänen K;
    Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):223-31. PubMed ID: 17098349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of hTERT Expression with Cervical Cytological Abnormalities and Human Papillomavirus Infection.
    Zejnullahu VA; Zejnullahu VA; Josifovska S; Vukovik N; Pakovski K; Panov S
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Dec; 38(3):143-151. PubMed ID: 29668478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Klotho expression in cervical cancer: differential expression in adenocarcinoma and squamous cell carcinoma.
    Aviel-Ronen S; Rubinek T; Zadok O; Vituri A; Avivi C; Wolf I; Barshack I
    J Clin Pathol; 2016 Jan; 69(1):53-7. PubMed ID: 26209729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.